Malaria: Relative Bioavailability and Food Effect of DSM265
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
Phase 1 study designed to evaluate the relative bioavailability of a single dose of a test formulation, DSM265-TPGS 34% SDD powder in comparison with a reference DSM265 25% SDD powder formulation used in early clinical trials.
Key facts
- Study ID
- NCT03637517
- Run by
- Medicines for Malaria Venture
- People needed
- 42
- Starts
- 2018-10-03
- Expected to finish
- 2018-11-19
- Last updated by the study team
- 2020-03-11
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- AbbVie Clinical Pharmacology Research Unit (ACPRU) — Grayslake, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.